DHI Capex To Revenue vs Ptb Ratio Analysis
DHI Stock | USD 172.94 9.41 5.75% |
DR Horton financial indicator trend analysis is much more than just examining DR Horton latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DR Horton is a good investment. Please check the relationship between DR Horton Capex To Revenue and its Ptb Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
Capex To Revenue vs Ptb Ratio
Capex To Revenue vs Ptb Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DR Horton Capex To Revenue account and Ptb Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between DR Horton's Capex To Revenue and Ptb Ratio is -0.25. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Ptb Ratio in the same time period over historical financial statements of DR Horton, assuming nothing else is changed. The correlation between historical values of DR Horton's Capex To Revenue and Ptb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of DR Horton are associated (or correlated) with its Ptb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ptb Ratio has no effect on the direction of Capex To Revenue i.e., DR Horton's Capex To Revenue and Ptb Ratio go up and down completely randomly.
Correlation Coefficient | -0.25 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most indicators from DR Horton's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DR Horton current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.As of now, DR Horton's Enterprise Value Multiple is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 10.5B | 9.4B | 9.5B | 10.0B | Total Revenue | 33.5B | 35.5B | 36.8B | 38.6B |
DR Horton fundamental ratios Correlations
Click cells to compare fundamentals
DR Horton Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DR Horton fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 18.9B | 24.0B | 30.4B | 32.6B | 36.1B | 37.9B | |
Short Long Term Debt Total | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.9B | |
Total Current Liabilities | 2.5B | 3.4B | 4.5B | 4.4B | 7.3B | 7.6B | |
Total Stockholder Equity | 11.8B | 14.9B | 19.4B | 22.7B | 25.3B | 26.6B | |
Property Plant And Equipment Net | 683.7M | 114.6M | 152.8M | 445.4M | 531M | 557.6M | |
Net Debt | 1.3B | 2.2B | 3.5B | 1.2B | 1.4B | 1.9B | |
Retained Earnings | 9.8B | 13.6B | 19.2B | 23.6B | 28.0B | 29.3B | |
Accounts Payable | 900.5M | 1.2B | 1.4B | 1.2B | 1.3B | 1.4B | |
Cash | 3.0B | 3.2B | 2.5B | 3.9B | 4.5B | 4.8B | |
Non Current Assets Total | 2.1B | 2.3B | 3.7B | 3.8B | 694.5M | 1.3B | |
Non Currrent Assets Other | (688.5M) | 1.6B | 515.2M | 3.4B | (167.5M) | (159.1M) | |
Cash And Short Term Investments | 3.0B | 3.2B | 2.5B | 3.9B | 4.5B | 4.7B | |
Common Stock Shares Outstanding | 370.2M | 365.8M | 354.8M | 343.3M | 329.5M | 321.9M | |
Liabilities And Stockholders Equity | 18.9B | 24.0B | 30.4B | 32.6B | 36.1B | 37.9B | |
Non Current Liabilities Total | 4.3B | 5.4B | 6.1B | 5.1B | 3.0B | 2.7B | |
Inventory | 12.2B | 16.5B | 21.7B | 22.4B | 24.9B | 26.1B | |
Other Current Assets | 1.3B | 1.7B | 4.2B | 2.1B | 2.5B | 2.6B | |
Other Stockholder Equity | 2.1B | 1.2B | 207M | (897.6M) | (2.6B) | (2.5B) | |
Total Liab | 6.8B | 8.8B | 10.6B | 9.4B | 10.3B | 10.8B | |
Property Plant And Equipment Gross | 104.4M | 114.6M | 152.8M | 64.6M | 70M | 120.0M | |
Total Current Assets | 16.8B | 21.7B | 26.6B | 28.8B | 29.4B | 30.9B | |
Short Term Debt | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.0B | |
Other Current Liab | (2.8B) | (3.4B) | (3.2B) | 3.1B | 3.0B | 3.2B | |
Other Assets | 201M | 5.1B | 5.4B | 213.7M | 6.0B | 6.3B | |
Long Term Debt | 4.3B | 5.4B | 6.1B | 5.1B | 5.9B | 3.7B | |
Treasury Stock | (802.2M) | (1.2B) | (2.0B) | (3.1B) | (2.8B) | (2.7B) | |
Property Plant Equipment | 683.7M | 392.9M | 471.6M | 445.4M | 512.2M | 537.8M | |
Other Liab | 685.5M | 871.3M | 1.3B | 1.2B | 1.0B | 618.4M | |
Current Deferred Revenue | 93.1M | 193.4M | 224.2M | (5.1B) | (4.6B) | (4.4B) | |
Net Receivables | 271.4M | 321.7M | 423.1M | 426.9M | 490.9M | 282.0M | |
Net Tangible Assets | 11.7B | 14.7B | 19.2B | 22.5B | 25.9B | 27.2B |
Currently Active Assets on Macroaxis
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 1.2 | Earnings Share 14.34 | Revenue Per Share 111.689 | Quarterly Revenue Growth (0.05) |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.